Dr Daniel Schwartz
  • Home
  • Privacy
  • About Dr. Daniel Schwartz
  • Contact
  • Docs
Select Page

PharmaCare in BC: Bridging the Gaps in Prescription Coverage

by Daniel Schwartz | Jul 24, 2025 | Health Policy

Access to Care PharmaCare in BC: Bridging the Gaps in Prescription Coverage     Medication coverage in British Columbia is meant to ensure everyone can get the drugs they need. Yet, in my experience, many patients still face barriers. In this post, I’ll...
Finerenone After RAAS and SGLT2 Inhibition: Is Triple Therapy Appropriate?

Finerenone After RAAS and SGLT2 Inhibition: Is Triple Therapy Appropriate?

by Daniel Schwartz | Nov 28, 2022 | Clinical Trials, Health Policy

CLINICAL TRIALS Should patients with diabetes, CKD and proteinuria despite RAASi & SGLT2i be considered for add-on therapy with finerenone (triple therapy)? A recent Twitter thread: As a Canadian nephrologist, relevant & active national debate in light of...
Temporary Resident Visas for Living Kidney Donors

Temporary Resident Visas for Living Kidney Donors

by Daniel Schwartz | Aug 19, 2015 | Health Policy

HEALTH POLICY Temporary Visitor Visas for Donating a KidneY This is a highly subjective list, but these trials have been included as they have had a meaningful impact on guidelines, patients and clinicians at a global scale. As a resident in the newly created...

Recent Thoughts

  • SGLT2 Inhibitors at Low GFR: Are We Drawing the Line in the Wrong Place?
  • PharmaCare in BC: Bridging the Gaps in Prescription Coverage
  • Reducing Prescription Drug Costs in Canada
  • Tips for Starting an SGLT2 Inhibitor
  • Ten Ways Health IT Could Improve Access to Physicians
  • Finerenone After RAAS and SGLT2 Inhibition: Is Triple Therapy Appropriate?
  • Most Impactful Clinical Trials for Slowing CKD Progression
  • How EMPA-KIDNEY Changed Clinical Care in CKD
  • Personalized Decision Support: From NNT to iNNT
  • Could SPRINT Change the Systolic Blood Pressure Target?

Recent Comments

    Contact

    100-200 Keary St
    New Westminster, BC  V3L 0A6

    (604) 516-7774

    Learn More

    LinkedIn

    RateMDs

    UBC

    Magic

    • SGLT2 Inhibitors at Low GFR: Are We Drawing the Line in the Wrong Place?
    • PharmaCare in BC: Bridging the Gaps in Prescription Coverage
    • Reducing Prescription Drug Costs in Canada
    • Tips for Starting an SGLT2 Inhibitor
    • Ten Ways Health IT Could Improve Access to Physicians